MARC details
| 000 -LEADER |
|---|
| fixed length control field |
03214cam a22003255i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
BD-DhNSU-30324 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
BD-DhNSU |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20240116134330.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
240116s2021 nyua|||g 000 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9783030762629 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9783030762636 (eBook) |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
BD-DhNSU |
| Transcribing agency |
BD-DhNSU |
| 041 ## - LANGUAGE CODE |
|---|
| Language code of text |
eng |
| 050 ## - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RC271 |
| Item number |
.C5C36 2021 |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Cancer nanotheranostics, |
| Number of part/section of a work |
Vol. 2 / |
| Statement of responsibility, etc. |
edited by Muthupandian Saravanan and Hamed Barabadi. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
Cham : |
| Name of publisher, distributor, etc. |
Springer, |
| Date of publication, distribution, etc. |
c2021. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xiv, 368p. : |
| Other physical details |
ill., figs. ; |
| Dimensions |
25 cm. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Includes bibliographical references and index. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
Nanotechnology is an interdisciplinary research field that integrates chemistry, engineering, biology, and medicine. Nanomaterials offer tremendous opportunity as well as challenges for researchers. Of course, cancer is one of the world's most common health problems, responsible for many deaths. Exploring efficient anticancer drugs could revolutionize treatment options and help manage cancer mortality. Nanomedicine plays a significant role in developing alternative and more effective treatment strategies for cancer theranostics. This book mainly focuses on the emerging trends using nanomaterials and nanocomposites as alternative anticancer materials. The book is divided into three main topic areas: how to overcome existing traditional approaches to combat cancer, applying multiple mechanisms to target the cancer cells, and how nanomaterials can be used as effective carriers. The contents highlight recent advances in interdisciplinary research on processing, morphology, structure, and properties of nanostructured materials and their applications to combat cancer. Cancer Nanotheranostics is comprehensive in that it discusses all aspects of cancer nanotechnology. Because of the vast amount of information, it was decided to split this material into two volumes. In the first volume of Cancer Nanotheranostics, we discuss the role of different nanomaterials for cancer therapy, including lipid-based nanomaterials, protein and peptide-based nanomaterials, polymer-based nanomaterials, metal-organic nanomaterials, porphyrin-based nanomaterials, metal-based nanomaterials, silica-based nanomaterials, exosome-based nanomaterials and nano-antibodies. In the second volume, we discuss the nano-based diagnosis of cancer, nano-oncology for clinical applications, nano-immunotherapy, nano-based photothermal cancer therapy, nano-erythrosomes for cancer drug delivery, regulatory perspectives of nanomaterials, limitations of cancer nanotheranostics, the safety of nano-biomaterials for cancer nanotheranostics, multifunctional nanomaterials for targeting cancer nanotheranostics, and the role of artificial intelligence in cancer nanotheranostics |
| 526 ## - STUDY PROGRAM INFORMATION NOTE |
|---|
| Program name |
Pharmaceutical Science |
| 526 ## - STUDY PROGRAM INFORMATION NOTE |
|---|
| Program name |
Public Health |
| 590 ## - LOCAL NOTE (RLIN) |
|---|
| Documentalist |
Sumaiya Kainat Bintey Kohinoor |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Neoplasms |
| General subdivision |
drug therapy |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Theranostic Nanomedicine |
| General subdivision |
methods |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Tumor Microenvironment |
| General subdivision |
drug effects |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Nanoparticle Drug Delivery System |
| General subdivision |
pharmacology |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Saravanan, Muthupandian |
| Relator term |
editor |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Barabadi, Hamed |
| Relator term |
editor |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
lcc |
| Koha item type |
BK |
| 999 ## - SYSTEM CONTROL NUMBERS (KOHA) |
|---|
| -- |
30324 |
| -- |
30324 |
North South University Library OPAC